INHIBITION OF STRUCTURAL JOINT DAMAGE WITH UPADACITINIB AS MONOTHERAPY OR IN COMBINATION WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Peterfy, Charles G. [1 ]
Genovese, Mark C. [2 ]
Song, In-Ho [3 ]
Friedman, Alan [3 ]
Hall, Stephen [4 ]
Mysler, Eduardo [5 ]
Durez, Patrick [6 ]
Baraliakos, Xenofon [7 ]
Enejosa, Jeffrey V. [3 ]
Shaw, Tim [3 ]
Li, Yihan [3 ]
Chen, Su [3 ]
Strand, Vibeke [2 ]
机构：
[1] Spire Sci Inc, Kentfield, CA USA
[2] Stanford Univ, Palo Alto, CA 94304 USA
[3] AbbVie Inc, N Chicago, IL USA
[4] Monash Univ, Cabrini Hlth & Emeritus Res, Malvern, Australia
[5] Org Med Invest, Buenos Aires, DF, Argentina
[6] Catholic Univ Louvain, Clin Univ St Luc, Brussels, Belgium
[7] Herne & Ruhr Univ, Bochum, Germany
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2020年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
128
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [1] Inhibition of Structural Joint Damage with Upadacitinib as Monotherapy or in Combination with Methotrexate in Patients with Rheumatoid Arthritis
    Peterfy, Charles
    Genovese, Mark
    Song, In-Ho
    Friedman, Alan
    Hall, Stephen
    Mysler, Eduardo
    Durez, Patrick
    Baraliakos, Xenofon
    Enejosa, Jose Jeff Rey
    Shaw, Tim
    Li, Yihan
    Chen, Su
    Strand, Vibeke
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [2] INHIBITION OF STRUCTURAL JOINT DAMAGE WITH UPADACITINIB AS MONOTHERAPY OR IN COMBINATION WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: 1 YEAR OUTCOMES FROM THE SELECT PHASE 3 PROGRAM
    Peterfy, Charles
    Genovese, Mark C.
    Song, In-Ho
    Friedman, Alan
    Hall, Stephen
    Mysler, Eduardo
    Durez, Patrick
    Baraliakos, Xenofon
    Enejosa, Jose Jeffrey
    Shaw, Tim
    Li Yihan
    Su Chen
    Strand, Vibeke
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 369 - 370
  • [3] Radiographic Outcomes in Patients with Rheumatoid Arthritis Receiving Upadacitinib as Monotherapy or in Combination with Methotrexate: Results at 2 Years
    Peterfy, Charles
    Strand, Vibeke
    Genovese, Mark
    Friedman, Alan
    Enejosa, Jeffrey
    Hall, Stephen
    Mysler, Eduardo
    Durez, Patrick
    Baraliakos, Xenofon
    Shaw, Tim
    Song, Yanna
    Li, Yihan
    Song, In-Ho
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [4] RADIOGRAPHIC OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING UPADACITINIB AS MONOTHERAPY OR IN COMBINATION WITH METHOTREXATE: RESULTS AT 2 YEARS
    Hall, Stephen
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 47 - 47
  • [5] LEUCOPENIA IN RHEUMATOID ARTHRITIS PATIENTS PRESCRIBED METHOTREXATE AS COMBINATION OR MONOTHERAPY
    Reynolds, Neal D.
    Edwards, Mark H.
    Hull, Richard G.
    Ledingham, Joanna M.
    RHEUMATOLOGY, 2009, 48 : I61 - I61
  • [6] UPADACITINIB MONOTHERAPY IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS
    Rischmueller, Maureen
    Takeuchi, Tsutomu
    Rischmueller, Maureen
    Blanco, Ricardo
    Xavier, Ricardo
    Howard, Mark
    Friedman, Alan
    Song, Yanna
    Strand, Vibeke
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 47 - 47
  • [7] Upadacitinib Monotherapy in Methotrexate-naive Patients with Rheumatoid Arthritis: Results at 72 Weeks
    van Vollenhoven, Ronald
    Takeuchi, Tsutomu
    Rischmueller, Maureen
    Blanco, Ricardo
    Xavier, Ricardo
    Howard, Mark
    Friedman, Alan
    Song, Yanna
    Strand, Vibeke
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [8] Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate
    Cohen, Stanley B.
    Keystone, Edward
    Genovese, Mark C.
    Emery, Paul
    Peterfy, Charles
    Tak, Paul Peter
    Cravets, Matt
    Shaw, Tim
    Hagerty, David
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (06) : 1158 - 1161
  • [9] Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 84 Weeks
    Smolen, Josef
    Emery, Paul
    Rigby, William
    Tanaka, Yoshiya
    Vargas, Juan
    Damjanov, Nemanja
    Jain, Manish
    Song, Yanna
    Khan, Nasser
    Enejosa, Jeffrey
    Cohen, Stanley
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [10] A comparative analysis of upadacitinib monotherapy and upadacitinib combination therapy for the treatment of rheumatoid arthritis from two
    Andrea, Rubbert-Roth
    Maya, Buch H.
    Alvin, Wells F.
    Manish, Jain
    Casey, Schlacher
    Heidi, Camp S.
    Li Yihan
    Song Yanna
    Peter, Nash
    SWISS MEDICAL WEEKLY, 2019, : 8S - 8S
12345